From Prevention to Community Integration: IPCST for Severe Mental Illness in Chinese Communities (Hong Kong and Beijing)
From Prevention to Community Integration: Service Models, Intervention Strategies, and Outcome Evaluation for Recovery From Severe Mental Illness in Chinese Communities (Hong Kong and Beijing)
This research project aims at early detection, early intervention, and recovery of individuals with psychosis and prevention of their family members who are at high risk of having developmental problems and developing psychosis episode in later stages of their life.
It consists of two major parts with the following study designs & aims:
Part I : Developing a comprehensive and integrative psychosocial and community skills training programme (IPCST) and conducing a pilot randomised controlled trial to compare the study outcomes between the two settings in Hong Kong and Beijing.
- To develop IPCST as an innovative intervention model targeting individuals with first or recent onset of psychosis to reduce their stay in mental hospital and bridges them to independent living in the community with optimal social and professional support;
- To evaluate IPCST in terms of the clinical, vocational, and psychosocial outcomes of participants using a randomized controlled trial design and compare these outcomes between Hong Kong and Beijing;
- To examine the cost-effectiveness of IPCST in the two cities; and
- To train professionals and research personnel in Hong Kong and mainland for implementation
Part II: Exploring the health needs of younger family members of individuals with early psychosis and the strategies in preventing this clinical high risk group from developing psychotic episode and developmental problems in later stages of their lives.
- To identify the potential developmental problems or sufferings of theses younger family members living with patients with mental illness;
- To provide baseline assessment of their psychosocial stress, mental health, and quality of life;
- To identify interventions that may prevent them from developing psychosis and other developmental problems and improve their mental health.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This research is to develop and test on a pilot basis the clinical efficacy of the IPCST on the clinical and recovery outcomes of outpatients with first and recent-onset psychosis in one-year follow-up period in one regional outpatient care service of both Hong Kong and Beijing, China. All outcomes will be assessed by a trained Research Assistant who is blind to group assignment in each city separately. In Hong Kong, the study venue will be one Early Assessment Service for Young People with Early Psychosis (EASY) in Kwai Chung Hospital under the Kowloon West Hospital Cluster, Hospital Authority Hong Kong. In Beijing, the study venues consist of the Sixth Hospital of Peking University, the Chaoyang Third Hospital, and the Haidian Mental Health Hospital.
In both sites, the study venues are serving for first or recent-onset psychosis residing in the community.
Similar to previous psychosocial interventional studies, the primary outcomes of this study are patients' mental status and level of functioning. Secondary outcomes include the rate and length of psychiatric hospitalizations, vocational status, social skills, family functioning, and quality of life.
A total of 100 participants would be recruited for this project, 50 to be recruited from Hong Kong Kwai Chung; 50 to be recruited from mainland China sites.
Part I: Participants of this part will be randomly allocated to experimental or control group.
Experimental group participants will receive a 12-week, 48-hours of IPCST programme which includes both individual and group training on psychoeducation, motivational interviewing skills, neurocognitive and social cognition, and augmented supported employment with social skills.
Control group participants will receive the usual psychiatric treatment they have been receiving from the hospital.
All participants will receive assessment on their primary (symptom severity and functioning) and secondary (re-hospitalisation rates, family functioning, social skills, and employment status and satisfaction, and quality of life) outcomes at baseline and immediately (Post-test 1), 6 months (Post-test 2), and 12 months (Post-test 3) after completion of the interventions by a research assistant. Each assessment episode lasts about 1.5 hours.
Part II: Participants of this part will undergo a 30 minutes to 1 hour individual interview conducted by a research assistant that covers semi-structured open-ended questions and basic assessment of psychosocial stress, health and mental health status, and quality of life using quantitative measures.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Hong Kong/ China residents
- Age between 18-55 years;
- Primary diagnosis of psychosis (not more than 12 months of clinical diagnosis) by psychiatrist and confirmed with the SCID-I for DSM-IV TR Axis I Disorders (Biometrics Research, 2002);
- Primary six or above education;
- Mentally competent to follow the instructions and training and give informed written consent, as suggested by the attending psychiatrist;
- Able to communicate in Chinese;
- Intend to seek employment.
Exclusion Criteria:
- Co-morbidity of learning disability, neurological disorder (e.g., epilepsy) and organic brain disease, or clinically significant medical diseases;
- Recently participated or are participating in other structured psychosocial intervention, and/or
- Visual, language or communication difficulty.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: IPCST
Intervention = Patients that participate in IPCST programme
|
Integrative Psychosocial & Community Skills Training (IPCST) programme The IPCST programme includes:
|
|
Comparador activo: E.A.S.Y
Treatment as usual = Patients of E.A.S.Y Programme in HK Kwai Chung Hospital
|
The E.A.S.Y. (Early Assessment Service for Young People with Early Psychosis) Programme is a service programme for people suffering from early psychosis. The E.A.S.Y programme includes:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change of Positive and Negative Syndrome Scale (PANSS) score
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
The Positive and Negative Syndrome Scale (PANSS) is a medical scale used for measuring symptom severity of patients with schizophrenia. Participants will be assessed by medical specialist who will complete their PANSS at baseline, immediately following the completion of the 3-month program, and at 6- & 12- months after completion of the program. The Change of PANSS score over the above time course is the study's primary outcome measure. |
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
|
Change of The Personal and Social Performance Scale (PSP) score
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
The Personal and Social Performance scale (PSP) is widely used to assess social functioning in patients with schizophrenia. Participants will be assessed by medical specialist who will complete their PSP score at baseline, immediately following the completion of the 3-month program, and at 6- & 12- months after completion of the program. The Change of PSP score over the above time course is the study's primary outcome measure. |
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change of Employment Outcome Checklist (EOC) score
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
The Employment Outcome Checklist (EOC) is used to assess participants' employment outcomes such as the number of job interviews attended, the number of jobs obtained, number of hours per week worked, and salary received from each of the jobs that were obtained . Participants will be assessed by research assistant who will complete their EOC questionnaire at baseline, immediately following the completion of the 3-month program, and at 6- & 12- months after completion of the program. The Changes in EOC over the above time course is the study's secondary outcome measure. |
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
|
Change of The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) score
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) is a self-report quality of life measure for people with schizophrenia. Participants complete on their own the SQLS-R4 questionnaire at baseline, immediately following the completion of the 3-month program, and at 6- & 12- months after completion of the program. The Change of SQLS-R4 score over the above time course is the study's secondary outcome measure. |
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
|
Change of the Vocational Social Skills Assessment Scale (VSSS) score
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
The Vocational Social Skills Assessment Scale (VSSS) is a self-administered checklist that measures the participants' subjective perception of their competence in handling work-related social situations. Participants complete on their own the VSSS questionnaire at baseline, immediately following the completion of the 3-month program, and at 6- & 12- months after completion of the program. The Change of VSSS score over the above time course is the study's secondary outcome measure. |
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
|
Change of Re-hospitalization rate
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
Re-Hospitalization rate measured at Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
|
Change of outpatient follow-up rate
Periodo de tiempo: Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
The changes in outpatient follow-up rate measured at Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
Baseline, Completion of the 3-month program, and follow up at 6-, 12- month
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Anticipado)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 1-ZVKP
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .